Citruslabs
Santa Monica, California, 90404, United States
Location status: Recruiting
NCT Number: NCT06700915
This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Santa Monica, California, 90404, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Time frame: Baseline, Week 12, and Week 24
Evaluation of the effect of Diaberine on blood sugar regulation as measured by changes in HbA1c
Time frame: Baseline, Week 12, and Week 24
Evaluation of the effect of Diaberine on metabolism, as measured by changes in lipid panel levels.
Time frame: Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24; Weight: Baseline and Week 24
Assessment of participant-reported quality of life via a questionnaire.
Time frame: Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24; Weight: Baseline and Week 24
Evaluation of changes in participant weight.
Contact information is provided by the study sponsor or research team.
Ultimate International, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03016806
Acute Leukemia, Anemia
Rochester, New York, United States
View Trial DetailsNCT05732909
Acid-Base Imbalance, Acidosis
Aarhus, Aarhus N, Denmark
View Trial DetailsNCT06899958
Metabolic Diseases, Metabolism Disorder
Boston, Massachusetts, United States
View Trial DetailsNCT05784506
Metabolic Diseases, Metabolism Disorder
Nanjing, Jiangsu, China
View Trial Details